Cheng Yeh Medical (4164), a leading provider of radiotherapy oncology equipment and services, announced strong revenue performance for February 2026. The company's monthly revenue reached NT$269 million, representing a year-on-year increase of 22.8%. This growth reflects the stable recognition of equipment installation and service contracts with hospital clients, demonstrating its leadership position in the high-end medical market.
Company Code: 4164
Company Name: Cheng Yeh Medical
Industry: Biotechnology and Medical Industry
Data Month/Year: 2026-02
Current Month Revenue: NT$268,691 thousand (NT$269 million)
Year-on-year change from same month last year: +22.8%
FACT BOX
- Source: PR Times
- Category: 其他